title: Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.
abstract: WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Several lymph node staging strategies have been proposed as a response to the high morbidity seen after standard inguinal lymphadenectomy for penile cancer. A video-endoscopic (laparoscopic and robotic) approach has been proposed as a less morbid procedure in several retrospective studies. To date, none has evaluated the oncological adequacy with regard to whether all relevant nodes have been removed. To the authors' knowledge this is the first prospective study of a robotic or laparoscopic inguinal lymphadenectomy that evaluates the oncological adequacy of this approach for penile cancer. The study shows that robotic inguinal lymphadenectomy allowed adequate staging of disease in the inguinal region by removing all relevant lymph nodes as assessed by an independent evaluating urological oncologist.
  
  
  OBJECTIVE
  To prospectively determine the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy (RAVEIL).
  
  
  METHODS
  Patients with T1-3N0 penile cancer were enrolled into a prospective phase I trial at a tertiary care institution from March 2010 to January 2012. All patients underwent an initial RAVEIL approach. Verification of adequacy of dissection was performed by an independent surgeon via a separate open incision at the conclusion of the RAVEIL procedure. Out of 10 patients, if more than two superficial inguinal fields with ≥2 nodes or more than four with ≥1 node remained within the superficial dissection field, the study would not proceed to phase II.
  
  
  RESULTS
  Of 10 enrolled patients two had inguinal metastases and all positive nodes were detected by RAVEIL. The remaining eight patients had no metastases, with a mean of nine (range 5-21) left and nine (range 6-17) right nodes removed. One inguinal field RAVEIL was converted to an open dissection. The verifying surgeon confirmed that 18 of 19 inguinal fields (94.7% in nine patients) had an adequate dissection. Two benign nodes were found just beneath Scarpa's fascia above the inguinal dissection field. Limitations of the study include an inability to determine decisively what specific wound complications were related to RAVEIL because of the protocol-specified creation of a small inguinal incision for verification of adequate dissection.
  
  
  CONCLUSIONS
  RAVEIL allowed adequate staging of disease in the inguinal region among patients with penile cancer at risk for inguinal metastases.
authors.affiliation: Department of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. surmatin@mdanderson.org
authors.forename: Surena F
authors.initials: SF
authors.lastname: Matin
authors.forename: Janice N
authors.initials: JN
authors.lastname: Cormier
authors.forename: John F
authors.initials: JF
authors.lastname: Ward
authors.forename: Louis L
authors.initials: LL
authors.lastname: Pisters
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Wood
authors.forename: Colin P N
authors.initials: CP
authors.lastname: Dinney
authors.forename: Richard E
authors.initials: RE
authors.lastname: Royal
authors.forename: Xuelin
authors.initials: X
authors.lastname: Huang
authors.forename: Curtis A
authors.initials: CA
authors.lastname: Pettaway
mesh_terms: D006801:Humans; D007264:Inguinal Canal / Q000473:pathology* / Q000601:surgery; D010535:Laparoscopy; D008197:Lymph Node Excision / Q000295:instrumentation* / Q000379:methods; D008297:Male; D009367:Neoplasm Staging; D010412:Penile Neoplasms / Q000473:pathology / Q000601:surgery*; D010413:Penis / Q000473:pathology / Q000601:surgery*; D011446:Prospective Studies; D012371:Robotics; D020535:Video-Assisted Surgery
references.citation: Eur Urol. 2010 Jun;57(6):1002-12
references.pmid: 20163910
references.citation: Tumori. 1984 Dec 31;70(6):529-33
references.pmid: 6531796
references.citation: Arch Esp Urol. 2006 Oct;59(8):849-52
references.pmid: 17153511
references.citation: Int J Gynecol Cancer. 2004 Jul-Aug;14(4):621-4
references.pmid: 15304156
references.citation: J Urol. 2004 Jun;171(6 Pt 1):2191-4
references.pmid: 15126783
references.citation: Urology. 2009 Jan;73(1):167-70; discussion 170-1
references.pmid: 18829076
references.citation: Br J Plast Surg. 2002 Sep;55(6):510-1
references.pmid: 12479427
references.citation: J Urol. 1987 May;137(5):880-2
references.pmid: 3573181
references.citation: J Surg Oncol. 2006 Feb 1;93(2):133-8
references.pmid: 16425300
references.citation: J Endourol. 2007 Apr;21(4):364-7; discussion 367
references.pmid: 17451323
references.citation: Surg Today. 2004;34(5):413-8
references.pmid: 15108079
references.citation: Surg Gynecol Obstet. 1948 Dec;87(6):679-94
references.pmid: 18120502
references.citation: Eur J Surg Oncol. 2006 Sep;32(7):785-9
references.pmid: 16806794
references.citation: Ann Surg Oncol. 2011 Apr;18(4):977-82
references.pmid: 21184190
references.citation: J Am Coll Surg. 2003 Mar;196(3):442-50
references.pmid: 12648697
references.citation: J Urol. 1993 Mar;149(3):492-7
references.pmid: 8437253
references.citation: Arch Surg. 1992 Mar;127(3):281-6
references.pmid: 1550473
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3325-9
references.pmid: 19414668
references.citation: World J Urol. 2009 Apr;27(2):205-12
references.pmid: 18762945
references.citation: Indian J Urol. 2011 Jul;27(3):424-7
references.pmid: 22022077
references.citation: J Urol. 2007 Mar;177(3):953-7; discussion 958
references.pmid: 17296386
references.citation: J Urol. 2005 Mar;173(3):816-9
references.pmid: 15711276
references.citation: J Urol. 2008 Oct;180(4):1354-9
references.pmid: 18707720
references.citation: J Endourol. 2008 Aug;22(8):1687-91
references.pmid: 18657031
references.citation: Br J Plast Surg. 1992 Apr;45(3):211-3
references.pmid: 1596661
references.citation: J Urol. 2002 Apr;167(4):1638-42
references.pmid: 11912379
references.citation: J Urol. 2010 Jun;183(6):2227-32
references.pmid: 20399455